Literature DB >> 24407316

Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications.

Gabriella Ferrandina1, Alfredo Ercoli, Anna Fagotti, Francesco Fanfani, Valerio Gallotta, Alessandro P Margariti, Maria Giovanna Salerno, Vito Chiantera, Francesco Legge, Gabriella Macchia, Alessio G Morganti, Vincenzo Valentini, Giovanni Scambia.   

Abstract

BACKGROUND: We provided a comprehensive analysis of rate, pattern, and severity of early and late postoperative complications in a very large, single-institution series of locally advanced cervical cancer (LACC) patients administered CT/RT plus radical surgery (RS).
METHODS: A total of 362 consecutive LACC (FIGO stage IB2-IVA) patients were submitted to RS after CT/RT at the Gynecologic Oncology Unit of the Catholic University (Rome/Campobasso). At 4 weeks after CT/RT, patients were evaluated for objective response and triaged to radical hysterectomy and pelvic ± aortic lymphadenectomy. Surgical morbidity was classified according to the Chassagne's grading system.
RESULTS: Most cases underwent type III-IV radical hysterectomy (N = 313, 86.5 %); pelvic lymphadenectomy was performed in all patients, while 116 patients (32.1 %) were also submitted to aortic lymphadenectomy. A total of 93 patients (25.7 %) experienced any grade postoperative complications, and 60 (16.6 %) had ≥grade 2 complications; grade 3-4 complications occurred in 21 patients (5.8 %). Of all early postoperative complications (N = 100), 31 (31.0 %) were urinary, 9 (9.0 %) were gastrointestinal, and 45 (45.0 %) were vascular. Of all late complications (N = 31), 20 (64.5 %) were urinary, 7 (22.6 %) gastrointestinal, and 2 (6.4 %) were vascular. Multivariate analysis showed that not complete clinical response to treatment retained an independent, unfavorable association with risk of development of postoperative morbidity, while advanced stage, and aortic lymphadenectomy showed only a borderline value.
CONCLUSIONS: Failure to achieve clinical complete response to treatment and, to a lesser extent, more advanced stage, and aortic lymphadenectomy, were associated with a higher risk of developing any grade as well as ≥grade 2 complications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24407316     DOI: 10.1245/s10434-013-3471-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  20 in total

1.  Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.

Authors:  Giuseppe Vizzielli; Lucia Tortorella; Carmine Conte; Vito Chiantera; Valerio Gallotta; Nazario Foschi; Martina Arcieri; Gabriella Ferrandina; Anna Fagotti; Filiberto Zattoni; Giovanni Scambia; Alfredo Ercoli
Journal:  Ann Surg Oncol       Date:  2020-10-15       Impact factor: 5.344

2.  The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study.

Authors:  Vittoria Rufini; Angela Collarino; Maria Lucia Calcagni; Guido Maria Meduri; Valentina Fuoco; Tina Pasciuto; Antonia Carla Testa; Gabriella Ferrandina; Maria Antonietta Gambacorta; Maura Campitelli; Benedetta Gui; Gianfranco Zannoni; Riccardo Manfredi; Giovanni Scambia; Alessandro Giordano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-14       Impact factor: 9.236

Review 3.  Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.

Authors:  Fani Kokka; Andrew Bryant; Adeola Olaitan; Elly Brockbank; Melanie Powell; David Oram
Journal:  Cochrane Database Syst Rev       Date:  2022-08-22

4.  Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.

Authors:  Gabriella Macchia; Savino Cilla; Francesco Deodato; Francesco Legge; Aida Di Stefano; Vito Chiantera; Giovanni Scambia; Vincenzo Valentini; Alessio G Morganti; Gabriella Ferrandina
Journal:  Br J Radiol       Date:  2015-09-21       Impact factor: 3.039

5.  Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.

Authors:  Naoki Horikawa; Tsukasa Baba; Noriomi Matsumura; Ryusuke Murakami; Kaoru Abiko; Junzo Hamanishi; Ken Yamaguchi; Masafumi Koshiyama; Yumiko Yoshioka; Ikuo Konishi
Journal:  BMC Cancer       Date:  2015-10-19       Impact factor: 4.430

6.  Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis.

Authors:  Seung Hyuk Shim; Soo Nyung Kim; Su Hyun Chae; Jung Eun Kim; Sun Joo Lee
Journal:  J Gynecol Oncol       Date:  2018-01-05       Impact factor: 4.401

7.  Individualized pelvic lymphadenectomy should follow neoadjuvant concurrent chemoradiotherapy for locally advanced cervical cancer.

Authors:  Li-Chun Wei; Xin Li; Ying Zhang; Yun-Zhi Dang; Wei-Wei Li; Jian-Ping Li; Li-Na Zhao; Shu-Juan Liu; Xia Li; Mei Shi
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

8.  The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer.

Authors:  Simona Leonardi; Marianna Buttarelli; Ilaria De Stefano; Gabriella Ferrandina; Marco Petrillo; Gabriele Babini; Giovanni Scambia; Carmela Marino; Mariateresa Mancuso; Daniela Gallo
Journal:  Oncotarget       Date:  2017-10-09

Review 9.  Early and late onset complications of gynaecologic surgery: a multimodality imaging approach.

Authors:  I De Blasis; V Vinci; M E Sergi; F Capozza; M Saldari; F Moro; M C Moruzzi; A C Testa; L Manganaro
Journal:  Facts Views Vis Obgyn       Date:  2017-03

10.  Impact of HPV vaccination: health gains in the Italian female population.

Authors:  Andrea Marcellusi
Journal:  Popul Health Metr       Date:  2017-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.